SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0000903423-16-001337
Filing Date
2016-11-07
Accepted
2016-11-07 16:08:52
Documents
1

Document Format Files

Seq Description Document Type Size
1 glaxo-crspr13da1_1104.htm SC 13D/A 22026
  Complete submission text file 0000903423-16-001337.txt   23505
Mailing Address 980 GREAT WEST ROAD BRENTFORD MIDDLESEX X0 TW8 9GS
Business Address 980 GREAT WEST ROAD BRENTFORD MIDDLESEX X0 TW8 9GS 011442080475000
GLAXOSMITHKLINE PLC (Filed by) CIK: 0001131399 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0
Type: SC 13D/A
SIC: 2834 Pharmaceutical Preparations

Mailing Address AESCHENVORSTADT 36 BASEL V8 4051
Business Address AESCHENVORSTADT 36 BASEL V8 4051 6173154600
CRISPR Therapeutics AG (Subject) CIK: 0001674416 (see all company filings)

IRS No.: 473173478 | State of Incorp.: V8
Type: SC 13D/A | Act: 34 | File No.: 005-89674 | Film No.: 161978168
SIC: 2836 Biological Products, (No Diagnostic Substances)